Company QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

Market Closed - OTC Markets 09:44:45 2024-05-16 EDT 5-day change 1st Jan Change
0.118 USD +18.00% Intraday chart for QHSLab, Inc. +43.55% +31.11%

Business Summary

QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.

Sales per Business

USD in Million2022Weight2023Weight Delta
Allergy Diagnostic Kit
47.3 %
1 55.1 % 1 47.3 % -2.69%
Immunotherapy Treatment
25.8 %
0 39.0 % 0 25.8 % -25.03%
Integrated Service Program
19.2 %
0 0.7 % 0 19.2 % +3,218.45%
Subscription
5.1 %
0 1.5 % 0 5.1 % +287.05%
Shipping and Handling
2.3 %
0 2.9 % 0 2.3 % -9.25%
Training & Other
0.3 %
0 0.9 % 0 0.3 % -58.81%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1 100.0 % 1 100.0 % +13.34%

Managers

Managers TitleAgeSince
Chief Executive Officer 47 15-05-26
Investor Relations Contact - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 47 15-05-26

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 2,644,424 0 0 67.18 %
Stock B 1 10,215,508 6,863,183 ( 67.18 %) 0
Stock C 0 1,080,092 0 0

Shareholders

NameEquities%Valuation
3,352,145 32.81 % 251 411 $
Mercer Street Global Opportunity Fund LLC
11.39 %
1,163,077 11.39 % 87 231 $
NameEquities%Valuation
Troy Grogan
100.00 %
2,644,424 100.00 % 198 332 $
NameEquities%Valuation
Troy Grogan
100.00 %
1,080,092 100.00 % 81 007 $

Company contact information

QHSLab, Inc.

901 Northpoint Parkway Suite 302

33407, West Palm Beach

+929 379 6503

http://www.usaqcorp.com
address QHSLab, Inc.(USAQ)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW